How IBD activity affects frailty in people aged 60 and older
Official title: Impact of Inflamatory Bowel Disease Activity on Frailty in Patients Over 60 Years
Run by Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa · NCT06844318 · Data updated 2026-11-12
This project will see if active IBD worsens frailty and whether treating activity can reduce frailty and the risk of hospitalization or death in people aged 60 and up.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 153 (estimated) |
| Sponsor | Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa Academic / other |
| Locations | 34 sites (Vitoria-Gasteiz, Alava and 33 other locations) |
| Status | Recruiting |
| Started | April 14, 2025 |
| Main results expected | July 2026 |
| Study ends | May 2027 |
| Registry record updated | May 7, 2026 |
| Trial ID | NCT06844318 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 60 or older with Crohn's disease or ulcerative colitis (per ECCO criteria) who are under follow-up at a participating IBD unit and are starting medical treatment for clinically or biologically active disease and can give informed consent.
✕Probably not a fit
Patients with unclassified colitis, an ostomy, those whose treatment change is only for adverse events, those starting only topical/salicylate therapy, or with life expectancy under one year are excluded and unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, multicenter, longitudinal observational cohort of patients with Crohn's disease or ulcerative colitis aged 60 years or older who start medical treatment for clinically or biologically active disease. At enrolment four clinical frailty indices and comorbidity scores will be calculated and detailed IBD characteristics and treatments recorded. Participants will be reassessed at 3, 6, and 12 months for frailty, comorbidities, IBD activity, treatment changes, adverse events, hospitalizations, and mortality. The study will compare which frailty index best predicts complications and whether improvement in IBD activity is associated with reversal or reduction of frailty and related risks.
Why it matters
Potential benefit: If successful, this work could help clinicians identify older IBD patients at highest risk and guide treatment to reduce hospitalizations and deaths by targeting reversible frailty.
How similar studies have gone: Previous observational research has linked frailty to worse outcomes in older IBD and other chronic disease populations, but longitudinal data on reversibility with treatment and head-to-head comparisons of frailty indices in IBD are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged ≥60 years with IBD (Crohn's disease or ulcerative colitis) diagnosed according to ECCO criteria and under follow-up in the IBD units of participating centers. * Initiation of medical treatment (oral mesalazine, topical or systemic corticosteroids, immunosuppressants, and/or biologics) due to clinical activity based on PRO2 scales (UC: PRO \>4; CD: PRO2 \>14) and/or biological activity (fecal calprotectin ≥500 mg/kg, C-reactive protein ≥10 mg/L). * Signed informed consent for inclusion. Exclusion Criteria: * Lack or withdrawal of informed consent. * Unclassified/indeterminate colitis. * Change in medical treatment solely due to adverse events. * Initiation of treatment only with salicylates and/or topical steroids for disease activity. * Treatment intensification to manage disease activity. * Patients with an ostomy. * Comorbidities with a life expectancy of less than one year.
Where it's running
-
Hospital Universitario Araba
Vitoria-Gasteiz, Alava, Spain Recruiting -
Hospital Germans Trias i Pujol
Badalona, Barcelona, Spain Recruiting -
Hospital de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain Recruiting -
Althaia Manresa
Manresa, Barcelona, Spain Recruiting -
Hospital del Mataró
Mataró, Barcelona, Spain Recruiting -
Consorci Sanitari de Terrassa
Terrassa, Barcelona, Spain Recruiting
Show 28 more locations
-
Hospital Mútua de Terrassa
Terrassa, Barcelona, Spain Recruiting -
Hospital Viladecans
Viladecans, Barcelona, Spain Recruiting -
Hospital Sierrallana de Torrelavega
Torrelavega, Cantabria, Spain Recruiting -
Hospital de Toledo
Toledo, Castille-La Mancha, Spain Recruiting -
Hospital Universitario de Gran Canaria Doctor Negrín
Las Palmas de Gran Canaria, Las Palmas, Spain Recruiting -
Hospital de Henares
San Sebastián de los Reyes, Madrid, Spain Recruiting -
Hospital San Agustín de Avilés
Avilés, Principality of Asturias, Spain Recruiting -
Hospital de Cabueñes
Gijón, Principality of Asturias, Spain Recruiting -
Hospital Universitario Central de Astúrias
Oviedo, Principality of Asturias, Spain Recruiting -
Hospital Universitario de Canarias
San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain Recruiting -
Hospital Dr Balmis
Alicante, Valencia, Spain Recruiting -
Hospital Denia
Denia, Valencia, Spain Recruiting -
Hospital Royo Villanova
San Gregorio, Zaragoza, Spain Recruiting -
Complejo Asistencial de Ávila
Ávila, Spain Recruiting -
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain Recruiting -
Hospital Universitario de Burgos
Burgos, Spain Recruiting -
Hospital Universitari Dr Josep Trueta
Girona, Spain Recruiting -
Hospital Juan Ramón Jiménez
Huelva, Spain Recruiting -
Hospital Universitario Lucus Augusti
Lugo, Spain Recruiting -
Hospital Infanta Elena
Madrid, Spain Recruiting -
Hospital Puerta de Hierro Majadahonda
Madrid, Spain Recruiting -
Hospital Ramon y Cajal
Madrid, Spain Recruiting -
Hospital Universitario Infanta Leonor
Madrid, Spain Recruiting -
Complexo Hospitalario Universitario de Ourense
Ourense, Spain Recruiting -
Hospital Universitario Ntra. Sra. de Candelaria
Santa Cruz de Tenerife, Spain Recruiting -
Hospital General Universitario de Valencia
Valencia, Spain Recruiting -
Hospital Universitario de la Fe
Valencia, Spain Recruiting -
Hospital Lozano Blesa
Zaragoza, Spain Recruiting
Study contacts
- Principal investigator: Margalida Calafat, MD, PhD — Spanish Working Group on Crohn's disease and ulcerative colitis (GETECCU)
- Study coordinator: Erika Araya
- Email: secretariacientifica3@geteccu.org
- Phone: +34 674682070
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effect of Periodontal Therapy on Gut Microbes and Inflammation in People with Inflammatory Bowel Disease
This study tests whether treating gum disease in people with inflammatory bowel disease can influence the gut microbiome and markers of systemic inflammation.
-
Biological Collection to Help Create Models for Digestive Cancers and IBD
Researchers are gathering tissue and biological samples from patients with inflammatory bowel disease or digestive cancers to build personalized models and test new therapies.
-
Partial enteral nutrition to help IBD patients at nutritional risk maintain weight
We’re testing whether adding an oral nutritional supplement (LH VIOLA) to standard counseling helps adults with IBD who are at risk of malnutrition keep or gain weight over 16 weeks.
-
Maternal and infant microbiome links to infant gut inflammation and pregnancy outcomes in people with IBD
This project will see if mothers' microbiomes, diets, and breastmilk are linked to infant gut inflammation (measured by fecal calprotectin) in pregnant people with and without IBD.
-
Pregnancy in people with inflammatory bowel disease
This project will see if pregnancy changes how often women with IBD have disease flares by analyzing registry data from women who had pregnancies.
-
Gut bacteria and immune-cell energy in people with IBD and healthy adults
We will test whether gut bacteria change how immune cells use energy in people with Crohn's disease or ulcerative colitis and in healthy adults by using a short antibiotic course and a labeled fiber.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.